Skip to main content
TipRanks
Go Ultimate75% OFF

Arrowhead Pharmaceuticals (0HI3) Financial Statements

0 Followers

Arrowhead Pharmaceuticals Financial Overview

Arrowhead Pharmaceuticals's market cap is currently $6.25B. The company's EPS TTM is $-5.09; its P/E ratio is -8.79; Arrowhead Pharmaceuticals is estimated to report earnings on February 10, 2027, and the estimated EPS forecast is $-1.50. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Sep 26Sep 25Sep 24Sep 23Sep 22
Income Statement
Total Revenue$ 450.82M$ 829.45M$ 3.55M$ 240.74M$ 243.23M
Gross Profit$ 449.02M$ 829.45M$ -15.04M$ 228.24M$ 232.81M
Operating Income$ -707.17M$ 98.35M$ -601.08M$ -205.00M$ -178.51M
EBITDA$ -603.59M$ 164.82M$ -561.51M$ -175.67M$ -162.29M
Net Income$ -724.21M$ -1.63M$ -599.49M$ -205.28M$ -176.06M
Balance Sheet
Cash & Short-Term Investments$ 1.19B$ 919.37M$ 680.96M$ 403.63M$ 376.40M
Total Assets$ 1.74B$ 1.39B$ 1.14B$ 765.55M$ 691.94M
Total Debt$ 1.00B$ 366.28M$ 851.91M$ 383.50M$ 81.58M
Net Debt$ 937.46M$ 139.74M$ 749.23M$ 272.61M$ -26.43M
Total Liabilities$ 1.69B$ 881.88M$ 948.74M$ 478.39M$ 273.60M
Stockholders' Equity$ 50.31M$ 466.05M$ 185.44M$ 271.34M$ 398.52M
Cash Flow
Free Cash Flow$ -283.94M$ 156.89M$ -604.32M$ -330.63M$ -188.91M
Operating Cash Flow$ -271.95M$ 179.55M$ -462.85M$ -153.89M$ -136.13M
Investing Cash Flow$ -670.48M$ -129.29M$ -420.07M$ -96.16M$ -5.42M
Financing Cash Flow$ 776.82M$ 74.01M$ 870.52M$ 253.05M$ 65.19M

Currency in USD

Arrowhead Pharmaceuticals Earnings and Revenue History

-1B01B2B-20000 %-10000 %0 %10000 %EarningsProfit Margin2017201820192020202120222023202420252026RevenueEarningsProfit Margin

Arrowhead Pharmaceuticals Liabilities to Assets

0800M1.6B2.4B0 %40 %80 %120 %LiabilitiesLiabilities to Assets2017201820192020202120222023202420252026AssetsLiabilitiesLiabilities to Assets

Arrowhead Pharmaceuticals Cash Flow

-1B-500M0500M1B2017201820192020202120222023202420252026OperatingInvestingFinancing

Arrowhead Pharmaceuticals Forecast EPS vs Actual EPS

-4-3-2-101Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27EPS EstimateBeatMiss